Cervical dystonia: clinical and therapeutic features in 85 patients

We studied patients with cervical dystonia (CD) to determine clinical features and response to botulinum toxin A (BoNT/A). Patients were submitted to clinical, laboratory and neuroimaging evaluation. BoNT/A was injected locally in 81 patients using electromyographic guidance. Four patients who had h...

Full description

Saved in:
Bibliographic Details
Published in:Arquivos de neuro-psiquiatria 2008-03, Vol.66 (1), p.15-21
Main Authors: Camargo, Carlos Henrique F, Teive, Hélio A G, Becker, Nilson, Baran, Maria Helena Herdoíza, Scola, Rosana Hermínia, Werneck, Lineu César
Format: Article
Language:eng ; por
Subjects:
Adolescent
Adult
Aged
Botulinum Toxins, Type A - adverse effects
Botulinum Toxins, Type A - therapeutic use
Child
Child, Preschool
Electromyography
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neuromuscular Agents - adverse effects
Neuromuscular Agents - therapeutic use
NEUROSCIENCES
Pain Measurement
PSYCHIATRY
Severity of Illness Index
Torticollis - drug therapy
Treatment Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We studied patients with cervical dystonia (CD) to determine clinical features and response to botulinum toxin A (BoNT/A). Patients were submitted to clinical, laboratory and neuroimaging evaluation. BoNT/A was injected locally in 81 patients using electromyographic guidance. Four patients who had had previous treatment were considered to be in remission. The average ages at onset of focal dystonia and segmental dystonia were greater than for generalized dystonia (p
ISSN:0004-282X
1678-4227
1678-4227
0004-282X
DOI:10.1590/s0004-282x2008000100005